Trial Outcomes & Findings for Evaluating Wearable Robotic Assistance on Gait (NCT NCT04119063)

NCT ID: NCT04119063

Last Updated: 2024-01-10

Results Overview

The change in the metabolic energy required to walk will be measured using a portable metabolic measurement system (Cosmed K5). Units: change in % difference post vs pre gait training.

Recruitment status

COMPLETED

Study phase

EARLY_PHASE1

Target enrollment

6 participants

Primary outcome timeframe

Measured at the pre (day 1) and post (day 4) gait training assessments

Results posted on

2024-01-10

Participant Flow

All participants first completed higher frequency gait training followed by a washout period and then lower frequency gait training.

Participant milestones

Participant milestones
Measure
Gait Training With Exoskeleton Assistance
All participants received high frequency gait training followed by a washout period then low frequency gait training
Overall Study
STARTED
6
Overall Study
COMPLETED
6
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluating Wearable Robotic Assistance on Gait

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Exoskeleton Assistance
n=6 Participants
Gait training with exoskeleton assistance at higher and lower frequencies. powered orthosis: Novel powered leg brace to provide assistance during walking.
Age, Categorical
<=18 years
4 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
Sex: Female, Male
Male
5 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
5 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
6 participants
n=5 Participants

PRIMARY outcome

Timeframe: Measured at the pre (day 1) and post (day 4) gait training assessments

The change in the metabolic energy required to walk will be measured using a portable metabolic measurement system (Cosmed K5). Units: change in % difference post vs pre gait training.

Outcome measures

Outcome measures
Measure
Exoskeleton Gait Training High Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the higher frequency.
Exoskeleton Gait Training Low Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the lower frequency.
The Metabolic Energy Required to Walk
2.42 % change pre vs post gait training
Standard Deviation 16.87
-2.14 % change pre vs post gait training
Standard Deviation 10.59

PRIMARY outcome

Timeframe: Measured at the pre (day 1) and post (day 4) gait training assessments

The change in the walking speed will be measured over-ground using a stop watch. Units: % change between post vs pre assessments

Outcome measures

Outcome measures
Measure
Exoskeleton Gait Training High Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the higher frequency.
Exoskeleton Gait Training Low Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the lower frequency.
Change in Walking Speed
25.39 % change post vs pre training
Standard Deviation 14.65
8.09 % change post vs pre training
Standard Deviation 7.10

SECONDARY outcome

Timeframe: Measured at the pre (day 1) and post (day 4) gait training assessments

The change in the stride length will be measured by dividing the number of steps by distance traveled. Units: % change between post vs pre assessments.

Outcome measures

Outcome measures
Measure
Exoskeleton Gait Training High Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the higher frequency.
Exoskeleton Gait Training Low Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the lower frequency.
Change in Stride Length
16.28 % change post vs pre training
Standard Deviation 9.90
3.87 % change post vs pre training
Standard Deviation 5.00

SECONDARY outcome

Timeframe: Measured at the pre (day 1) and post (day 4) gait training assessments

The change in the number of steps taken per minute will be measured using a counter. Units: % change between post vs pre assessments.

Outcome measures

Outcome measures
Measure
Exoskeleton Gait Training High Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the higher frequency.
Exoskeleton Gait Training Low Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the lower frequency.
Change in Cadence
22.47 % change post vs pre training
Standard Deviation 35.18
4.04 % change post vs pre training
Standard Deviation 3.32

SECONDARY outcome

Timeframe: Measured at the pre (day 1) and post (day 4) gait training assessments

The change in the muscle activity variance ratio of the soleus during walking will be measured using electromyography electrodes. Units: % change between post vs pre assessments.

Outcome measures

Outcome measures
Measure
Exoskeleton Gait Training High Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the higher frequency.
Exoskeleton Gait Training Low Frequency
n=6 Participants
Gait training with ankle exoskeleton assistance at the lower frequency.
Change in Muscle Activity Variance Ratio
-47.24 % change post vs pre training
Standard Deviation 17.44
18.80 % change post vs pre training
Standard Deviation 29.97

Adverse Events

Gait Training With Exoskeleton Assistance High Frequency

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Gait Training With Exoskeleton Assistance Low Frequency

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Zach Lerner, Associate Professor

Northern Arizona University

Phone: 928-523-1787

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place